Common Stock (Tables)

3 Months Ended

Mar. 31, 2026

Common Stock [Abstract]

Schedule of Common Stock Reserved for Future Issuance

 As of March 31, 2026 and December 31, 2025, the Company had common stock reserved for future issuance as follows:

	March 31,		December 31,
	2026		2025
Outstanding and issued common stock options		2,671,358		2,246,206
Outstanding and issued restricted stock units		170,100		198,900
Outstanding and issued performance-based restricted stock units		—		20,000
Shares issuable upon exercise of Public Warrants (1)		499,986		499,986
Shares issuable upon exercise of Common Warrants		12,345,707		12,345,707
Shares issuable upon exercise of Pre-Funded Warrants		675,000		675,000
Shares available for grant under Equity Incentive Plans		418,817		843,360
Shares available for grant under Employee Stock Purchase Plan		920,827		920,827
Shares available for grant under 2022 Inducement Equity Incentive Plan		180,960		132,769
Total shares of common stock reserved		17,882,755		17,882,755

1) The Company has 4,999,863 outstanding warrants to purchase an aggregate of 499,986 shares of its common stock (the “Public Warrants”). A holder may purchase one share of the Company’s common stock for every ten Public Warrants at an exercise price of $115.00 per share. The Public Warrants are publicly traded and exercisable during the exercise period, which commenced on October 24, 2021 and ends on September 24, 2026, for cash or, in certain circumstances, on a cashless basis. The Public Warrants were reclassified to equity in January 2023.